COBISS Kooperativni online bibliografski sistem in servisi COBISS
Tudor Ciuleanu
Osebna bibliografija za obdobje 2006-2022
2006
1.
PETERSON, P., ZWITTER, Matjaž, KRZAKOWSKI, Maciej, WENCZL, M., TZEKOVA, V., RAMLAU,
R., CIULEANU, Tudor, LIEPA, A., ZIELINSKI, Christoph, BRODOWICZ, Thomas. Delay in
time to worsening of symptoms (TWS) of advanced non-small cell lung cancer (NSCLC)
using gemcitabine (gem) maintenance therapy. Journal of clinical oncology. [Print ed.]. 2006, vol. 24, no. 18s, str. 399s, 7140. ISSN 0732-183X. [COBISS.SI-ID
337787]
2007
2.
CIULEANU, Tudor, OCVIRK, Janja, et al. A randomized, open-label phase II study evaluating
the efficacy and safety of FOLFOX6 + Cetuximab versus FOLFIRI + Cetuximab as first-line
therapy in patients with metastatic colorectal cancer. European journal of cancer. Supplement. [Print ed.]. Sep. 2007, vol. 5, no. 4, str. 249. ISSN 1359-6349. [COBISS.SI-ID 540283]
2008
3.
BEŠLIJA, Semir, KOZA, I., OCVIRK, Janja, CIULEANU, Tudor, KURTEVA, G., PAPAMICHAEL,
D., VRBANEC, Damir, et al. Comparison of FOLFOX6 plus cetuximab with folfiri plus
cetuximab as first-line therapy in metastatic colorectal cancer (MCRC) : a randomized
open-label phase. V: Abstract book of the 33rd ESMO Congress, Stockholm, 12-16 September 2008. [S.l.]: Oxford University Press, 2008. Str. 168. Annals of Oncology, vol. 19, suppl.
8. ISSN 0923-7534. [COBISS.SI-ID 516451097]
4.
CIULEANU, Tudor, OCVIRK, Janja, et al. A randomized, open-label CECOG phase II study
evaluating the efficacy and safety of FOLFOX6 + cetuximab versus FOLFIRI + cetuximab
as first-line therapy in patients (pts) with metastatic colorectal cancer (mCRC).
Journal of clinical oncology. [Print ed.]. 2008, vol. 26, no. 15s, str. 186s. ISSN 0732-183X. [COBISS.SI-ID 670587]
5.
CIULEANU, Tudor, SCHEITHAUER, W., KURTEVA, G., OCVIRK, Janja, KOZA, I., PAPAMICHAEL,
D., WENCZL, M., BRODOWICZ, Thomas, BEŠLIJA, Semir, ZIELINSKI, Christoph. A randomized,
open-label phase II study evaluating the efficacy and safety of FOLFOX6 + cetuximab
versus FOLFIRI + cetuximab as first-line therapy in patients (pts) with metastatic
colorectal cancer (mCRC). V: Science and multidisciplinary management of GI malignancies : proceedings book. Alexandria, VA: American Society of Clinical Oncology, 2008. Str. 238. ISBN 978-1-932312-48-5.
[COBISS.SI-ID 590971]
2012
6.
VRDOLJAK, Eduard, CIULEANU, Tudor, KHARKEVICH, Galina, MARDIAK, Jozef, MEGO, Michal,
PADRIK, Peeter, PETRUŽELKA, Luboš, PURKALNE, Gunta, SHPARYK, Yaroslav, ŠKRBINC, Breda,
SZCZYLIK, Cezary, TORDAY, Laszlo. Optimizing treatment for patients with metastatic
renal cell carcinoma in the central and Eastern European region. Expert opinion on pharmacotherapy. Feb. 2012, vol. 13, no. 2, str. 159-174. ISSN 1465-6566. DOI: 10.1517/14656566.2012.647406. [COBISS.SI-ID 1460347]
2020
7.
ČUFER, Tanja, CIULEANU, Tudor, BERZINEC, Peter, GALFFY, Gabriela, JAKOPOVIĆ, Marko,
JASSEM, Jacek, JOVANOVIC, Dragana, MIHAYLOVA, Zhasmina, OSTOROS, Gyula, THALLINGER,
Christiane, ZEMANOVA, Milada, ZIELINSKI, Christoph. Access to novel drugs for non-small
cell lung cancer in Central and Southeastern Europe : a Central European Cooperative
Oncology Group analysis. The oncologist. [Online ed.]. Mar. 2020, vol. 25, iss. 3, str. e598-e601, ilustr. ISSN 1549-490X.
https://theoncologist.onlinelibrary.wiley.com/doi/epdf/10.1634/theoncologist.2019-0523, DiRROS - Digitalni repozitorij raziskovalnih organizacij Slovenije, DOI: 10.1634/theoncologist.2019-0523. [COBISS.SI-ID 2048592241]
8.
ZEMANOVA, Milada, JAKOPOVIĆ, Marko, STANIČ, Karmen, ŁAZAR-PONIATOWSKA, Małgorzata,
VRANKAR, Martina, RUSU, Petronela, CIULEANU, Tudor, RADOSAVLJEVIC, Davorin, BOGOS,
Krisztina, NAWROCKI, Sergiusz. Treatment patterns and real-world evidence for stage
III non-small cell lung cancer in Central and Eastern Europe. Radiology and oncology. [Print ed.]. 2020, vol. 54, no. 4, str. 447-453, vii, tabele. ISSN 1318-2099. https://content.sciendo.com/view/journals/raon/54/4/article-p447.xml, DiRROS - Digitalni repozitorij raziskovalnih organizacij Slovenije, http://www.dlib.si/details/URN:NBN:SI:DOC-TEB73KN8, DOI: 10.2478/raon-2020-0058. [COBISS.SI-ID 40405507]
2021
9.
PŁUŻAŃSKI, Adam, SHTEREV DONEV, Ivan, GAFTON, B., JANŽIČ, Urška, VIDOVIČ, Dušanka,
LUPU, Roxana, TEODORESCU, Gabriela, CIULEANU, Tudor. Real-world treatment patterns
and clinical outcomes in patients from Central Eastern Europe with EGFR-mutated advanced
non-small cell lung cancer : results from a large retrospective study (REFLECT). Annals of oncology. Supplement : an official Journal of the European Society for Medical
Oncology and the official journal of the Japanese Society of Medical Oncology, ESMO Congress 2021, 16-21 September 2021. Sep. 2021, vol. 32, suppl. 5, s973-s974.
ISSN 1572-610X. [COBISS.SI-ID 77816835]
10.
ADDEO, Alfredo, HOCHMAIR, Maximilian J, JANŽIČ, Urška, DUDNIK, Elizabeth, CHARPIDOU,
Andriani, PŁUŻAŃSKI, Adam, CIULEANU, Tudor, SHTEREV DONEV, Ivan, ELBAZ, Judith, AARØE,
Jørgen, OTT, René, PELED, Nir. Treatment patterns, testing practices, and outcomes
in the pre-FLAURA era for patients with EGFR mutation-positive advanced NSCLC : a
retrospective chart review (REFLECT). Therapeutic advances in medical oncology. 2021, vol. 13, str. 1-11, ilustr. ISSN 1758-8359. https://journals.sagepub.com/doi/pdf/10.1177/17588359211059874, DiRROS - Digitalni repozitorij raziskovalnih organizacij Slovenije, DOI: 10.1177/17588359211059874. [COBISS.SI-ID 89318403]
2022
11.
JANŽIČ, Urška, TURNŠEK, Nina, DEDIU, Mircea, SHTEREV DONEV, Ivan, LUPU, Roxana, TEODORESCU,
Gabriela, CIULEANU, Tudor, PŁUŻAŃSKI, Adam (avtor, korespondenčni avtor). Real-world
testing practices, treatment patterns and clinical outcomes in patients from Central
Eastern Europe with EGFR-mutated advanced non-small cell lung cancer : a retrospective
chart review study (REFLECT). Current oncology. Aug. 2022, vol. 29, iss. 8, str. 5833-5845, ilustr. ISSN 1198-0052. DiRROS - Digitalni repozitorij raziskovalnih organizacij Slovenije, DOI: 10.3390/curroncol29080460. [COBISS.SI-ID 119484931]